EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Markers of Metabolic Abnormalities in Vitiligo Patients

Federica Papaccio, Monica Ottaviani iD, Mauro Truglio iD, Andrea D'Arino iD, Silvia Caputo, Alessia Pacifico, Paolo Iacovelli, Anna Di Nardo iD, Mauro Picardo, Barbara Bellei iD

International Journal of Molecular Sciences · 23.09.2024 · 25 (18) · 10201

DOI: 10.3390/ijms251810201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.09.2024. Verfasst von Federica Papaccio und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, It…. Hauptthemen laut MEDLINE: Vitiligo, Biomarkers, Oxidative Stress, Metabolic Syndrome. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health (Ricerca Corrente 2024).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While vitiligo is primarily caused by melanocyte deficiency or dysfunction, recent studies have revealed a notable prevalence of metabolic syndrome (MetS) among patients with vitiligo. This suggests shared pathogenic features between the two conditions. Individuals with vitiligo often exhibit variations in triglyceride levels, cholesterol, and blood pressure, which are also affected in MetS. Given the similarities in their underlying mechanisms, genetic factors, pro-inflammatory signalling pathways, and increased oxidative stress, this study aims to highlight the common traits between vitiligo and metabolic systemic disorders. Serum analyses confirmed increased low-density lipoprotein (LDL) levels in patients with vitiligo, compared to physiological values. In addition, we reported significant decreases in folate and vitamin D (Vit D) levels. Oxidative stress is one of the underlying causes of the development of metabolic syndromes and is related to the advancement of skin diseases. This study found high levels of inflammatory cytokines, such as interleukin-6 (IL-6) and chemokine 10 (CXCL10), which are markers of inflammation and disease progression. The accumulation of insulin growth factor binding proteins 5 (IGFBP5) and advanced glycation end products (AGEs) entailed in atherosclerosis and diabetes onset, respectively, were also disclosed in vitiligo. In addition, the blood-associated activity of the antioxidant enzymes catalase (Cat) and superoxide dismutase (SOD) was impaired. Moreover, the plasma fatty acid (FAs) profile analysis showed an alteration in composition and specific estimated activities of FAs biosynthetic enzymes resembling MetS development, resulting in an imbalance towards pro-inflammatory n6-series FAs. These results revealed a systemic metabolic alteration in vitiligo patients that could be considered a new target for developing a more effective therapeutic approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoBiomarkersOxidative StressMetabolic SyndromeHumansMaleAdultFemaleMiddle AgedVitamin DLipoproteins, LDLCytokinesFatty AcidsCatalase

Stichwörter der Autor:innen

comorbiditiesinflammationmetabolic syndromevitiligo

Substanzen

BiomarkersVitamin DLipoproteins, LDLCytokinesFatty AcidsCatalase

Autor:innen und Institutionen

  • Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy.
  • Microbiology and Virology, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy.
  • Oncologic and Preventative Dermatology, San Gallicano Dermatological Institute, 00144 Rome, Italy.
  • Clinical Dermatology, Phototherapy Unit, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy.
  • Istituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.

ORCID-Profile: Monica Ottaviani, Mauro Truglio, Andrea D'Arino, Anna Di Nardo, Barbara Bellei

Förderung

  • Italian Ministry of Health (Ricerca Corrente 2024)

Zitieren

APA

Papaccio, F., Ottaviani, M., Truglio, M., D'Arino, A., Caputo, S., Pacifico, A., Iacovelli, P., Di Nardo, A., Picardo, M., & Bellei, B. (2024). Markers of Metabolic Abnormalities in Vitiligo Patients. International Journal of Molecular Sciences, 25(18), 10201. https://doi.org/10.3390/ijms251810201

Vancouver

Papaccio F, Ottaviani M, Truglio M, D'Arino A, Caputo S, Pacifico A, et al. Markers of Metabolic Abnormalities in Vitiligo Patients. International Journal of Molecular Sciences. 2024;25(18):10201. doi:10.3390/ijms251810201

BibTeX
@article{Papaccio2024,
  author = {Papaccio, Federica and Ottaviani, Monica and Truglio, Mauro and D'Arino, Andrea and Caputo, Silvia and Pacifico, Alessia and Iacovelli, Paolo and Di Nardo, Anna and Picardo, Mauro and Bellei, Barbara},
  title = {Markers of Metabolic Abnormalities in Vitiligo Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {18},
  pages = {10201},
  doi = {10.3390/ijms251810201}
}
Kostenlos starten →